- Home
- ABEO vs TSAT Comparison
ABEO vs TSAT Comparison
Compare ABEO & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- TSAT
- Stock Information
- Founded
- ABEO 1974
- TSAT 1969
- Country
- ABEO United States
- TSAT Canada
- Employees
- ABEO N/A
- TSAT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- TSAT Metal Fabrications
- Sector
- ABEO Health Care
- TSAT Industrials
- Exchange
- ABEO Nasdaq
- TSAT Nasdaq
- Market Cap
- ABEO 350.2M
- TSAT 394.3M
- IPO Year
- ABEO 1980
- TSAT 1996
- Fundamental
- Price
- ABEO $5.73
- TSAT $27.14
- Analyst Decision
- ABEO Strong Buy
- TSAT
- Analyst Count
- ABEO 6
- TSAT 0
- Target Price
- ABEO $18.17
- TSAT N/A
- AVG Volume (30 Days)
- ABEO 714.3K
- TSAT 88.4K
- Earning Date
- ABEO 11-13-2025
- TSAT 11-13-2025
- Dividend Yield
- ABEO N/A
- TSAT N/A
- EPS Growth
- ABEO N/A
- TSAT N/A
- EPS
- ABEO 0.99
- TSAT N/A
- Revenue
- ABEO $400,000.00
- TSAT $358,754,564.00
- Revenue This Year
- ABEO N/A
- TSAT N/A
- Revenue Next Year
- ABEO $324.71
- TSAT N/A
- P/E Ratio
- ABEO $5.80
- TSAT N/A
- Revenue Growth
- ABEO N/A
- TSAT N/A
- 52 Week Low
- ABEO $3.93
- TSAT $10.11
- 52 Week High
- ABEO $7.54
- TSAT $29.91
- Technical
- Relative Strength Index (RSI)
- ABEO 31.45
- TSAT 70.22
- Support Level
- ABEO $6.53
- TSAT $20.81
- Resistance Level
- ABEO $6.95
- TSAT $23.91
- Average True Range (ATR)
- ABEO 0.29
- TSAT 1.35
- MACD
- ABEO -0.12
- TSAT 0.56
- Stochastic Oscillator
- ABEO 3.39
- TSAT 91.37
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About TSAT Telesat Corporation
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.